Cobimetinib Nitroso Impurity 2

SZ目录编号:	SZ-C097004
CAS 号	NA
分子式	C21H19F3IN5O4
分子量	589.3
投资状态	Custom Synthesis

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.

化学名称: (S)-N-(2,3-Difluoro-6-(3-hydroxy-3-(1-nitrosopiperidin-2-yl)azetidine-1-carbonyl)phenyl)-N-(2-fluoro-4-iodophenyl)nitrous amide

Shipping Temperature: Ambient

HSN Code: 38229010

Country of Origin: India

微笑: O=C(C1=C(N(N=O)C2=CC=C(I)C=C2F)C(F)=C(F)C=C1)N(C3)CC3(O)[C@H]4N(N=O)CCCC4

Cobimetinib Nitroso Impurity 2 is chemically (S)-N-(2,3-Difluoro-6-(3-hydroxy-3-(1-nitrosopiperidin-2-yl)azetidine-1-carbonyl)phenyl)-N-(2-fluoro-4-iodophenyl)nitrous amide. Cobimetinib Nitroso Impurity 2 is supplied with detailed characterization data compliant with regulatory guideline. Cobimetinib Nitroso Impurity 2 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cobimetinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

SZ目录编号:	: SZ-C097D01
CAS 号	: 2714409-22-8
分子式	: C21H12D9F3IN3O2
分子量	: 540.4
投资状态	: Custom Synthesis
Rel. CAS No	: 934662-91-6 (Unlabeled)

Cobimetinib Nitroso Impurity 2

Contacts

Our Locations

SZ目录编号:	: SZ-C097001
CAS 号	: 934660-93-2
分子式	: C21H21F3IN3O2
分子量	: 531.3
投资状态	: Custom Synthesis

SZ目录编号:	: SZ-C097002
CAS 号	: NA
分子式	: C21H20F3IN4O3
分子量	: 560.3
投资状态	: Custom Synthesis

SZ目录编号:	: SZ-C097003
CAS 号	: NA
分子式	: C21H20F3IN4O3
分子量	: 560.3
投资状态	: Custom Synthesis

SZ目录编号:	: SZ-C097004
CAS 号	: NA
分子式	: C21H19F3IN5O4
分子量	: 589.3
投资状态	: Custom Synthesis

Cobimetinib Nitroso Impurity 2

Cobimetinib

Cobimetinib D9